| Pregnancy |
1 |
1 |
| Toxicology |
0 |
0.73 |
| Encephalopathy |
0 |
0.98 |
| Newborn |
0 |
0.71 |
| Cerebrovascular Accident |
0 |
0.63 |
| Hypoxic-Ischemic Encephalopathy |
0 |
0.95 |
| HIV Infection |
0 |
0.46 |
| Therapeutic Hypothermia |
0 |
0.29 |
| Depression |
0 |
0.27 |
| Hypothermia |
0 |
0.2 |
| Acidosis |
0 |
0.15 |
| Brain |
0 |
0.15 |
| Patient Safety |
0 |
0.15 |
| Electronic Health Record (EHR) and Healthcare Technology |
0 |
0.98 |
| Adverse Effects |
0 |
0.9 |
| Anxiety |
0 |
0.1 |
| Anxiety Disorder |
0 |
0.1 |
| Birth |
0 |
0.1 |
| California |
0 |
0.1 |
| Hospital |
0 |
0.1 |
| Injury |
0 |
0.1 |
| Wound Management |
0 |
0.1 |
| Genomic Medicine |
0 |
0.08 |
| Junior Doctors |
0 |
0.07 |
| Selective Serotonin-Reuptake Inhibitors |
0 |
0.99 |
| Antiretroviral Therapy for HIV Infection |
0 |
0.05 |
| Child |
0 |
0.05 |
| Fellowship |
0 |
0.05 |
| Genetics |
0 |
0.05 |
| Grant |
0 |
0.05 |
| Hypoxia |
0 |
0.05 |
| Ischemia |
0 |
0.05 |
| Jobs |
0 |
0.05 |
| Medical Innovations |
0 |
0.05 |
| Medical Life |
0 |
0.05 |
| Nucleoside Reverse Transcriptase Inhibitors |
0 |
0.05 |
| Resuscitation |
0 |
0.05 |